ArticleJAMA psychiatry2025
Prenatal and Early Postnatal Lead Exposure, Sensitive Periods, and Later Adult Mental Health.
Article in JAMA psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dentine markers of pre/early postnatal lead exposure links with brain, cognitive, and behavioral outcomes in adolescents.medRxiv : the preprint server for health sciences · 2026Article
- Blood Lead Concentrations and Depressive and Anxiety Symptoms in Childhood.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Importance: Early lead exposure is associated with psychological concerns in childhood, but less is known about sensitive periods of exposure or persistence into later adulthood. Objective: To examine the association between prenatal and early postnatal lead exposure and risk of anxiety and depression in later adulthood. Design, Setting, and Participants: This cohort study included participants from the Saint Louis Baby Tooth-Later Life Health Study (SLBT), who donated deciduous (baby) teeth in childhood during the 1950s through 1970s. SLBT participants were recontacted beginning in 2021 to complete health surveys and were masked to lead status. These data were analyzed from February 2025 through May 2025. Exposure: Lead exposure was measured in baby teeth across prenatal (approximately second trimester to birth, also split into second and approximately third trimesters), and early postnatal (birth to approximately 6 months old) periods. Main Outcomes and Measures: Self-reported depressive and anxiety symptoms were assessed via the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder Screener-7 (GAD-7) at a mean age of 62 (SD, 3.6) years. Outcomes were dichotomized using clinical cutoffs for major depressive disorder and generalized anxiety disorder. Secondary analyses treated outcomes as continuous symptom scores. Results: Of 5131 SLBT participants, 718 (13.3%) had their baby teeth analyzed for lead (381 female [53%] and 334 male [47%]). In total, 695 and 697 participants responded to the PHQ-9 and GAD-7, respectively. The median (25th-75th percentile) combined tooth lead concentration was 1.34 (95% CI, 1.02-1.82) ppm. After adjusting for covariates, an IQR increase in combined tooth lead was associated with nearly 2 times the odds of later adulthood depression (odds ratio, 1.90; 95% CI, 1.20-2.99). The late prenatal period (approximately third trimester) appeared to be the most sensitive window (odds ratio, 1.55; 95% CI, 1.23-1.97). There was no association between early lead exposure and major later adulthood generalized anxiety disorder, but late prenatal and postnatal lead were associated with greater later adulthood anxiety symptoms. Conclusions and Relevance: Third-trimester lead exposure was associated with higher risk of major depressive disorder and anxiety symptoms in later adulthood. These findings emphasize the importance of factoring in later life health outcomes when considering the benefits of lead exposure interventions in childhood and suggest investment in screening and mental health services may be needed to address the long-term burden of historical lead exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.